Evidence map›Paper›PMID 24248346›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

NFATc1 and NFATc2 repress spontaneous osteoarthritis.

Matthew B Greenblatt, Susan Y Ritter, John Wright, Kelly Tsang, Dorothy Hu, Laurie H Glimcher, Antonios O Aliprantis

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Biomedicines · 2025
    Review
  8. Article
  9. Role and Regulation of Transcription Factors in Osteoclastogenesis.International journal of molecular sciences · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Intergenic Interactions ofLife (Basel, Switzerland) · 2023
    Article
  14. Regulatory role of NFAT1 signaling in articular chondrocyte activities and osteoarthritis pathogenesis.Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Regulatory Mechanisms ofInternational journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Matthew B GreenblattDepartment of Pathology, Division of Rheumatology, Allergy and Immunology, Department of Medicine, and Department of Orthopedics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115.
Susan Y Ritter
John Wright
Kelly Tsang
Dorothy Hu
Laurie H Glimcher
Antonios O Aliprantis
Brigham and Women's Hospital · USCornell University · USENT and Allergy · USMassachusetts General Hospital · US

Funding

Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
Regulation of osteoclast biology by anion exchanger SLC4A2 in mouse and human sysR01AR060363 · NIAMS · HARVARD SCHOOL OF PUBLIC HEALTH · PI CHARLES, JULIA F · 2011 to 2015
$1.9M
Novel regulatory mechanisms of the osteoclast transcriptional programK08AR054859 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI ALIPRANTIS, ANTONIOS O · 2008 to 2012
$655k
NIAMS NIH HHS K08 AR054859NIAMS NIH HHS K08AR054859NIAMS NIH HHS R01 AR060363NIAMS NIH HHS R01AR060363-01NIGMS NIH HHS T32 GM007753
6 · The paper itself

Abstract

Osteoarthritis (OA) was once viewed originally as a mechanical disease of "wear and tear," but advances made during the past two decades suggest that abnormal biomechanics contribute to active dysregulation of chondrocyte biology, leading to catabolism of the cartilage matrix. A number of signaling and transcriptional mechanisms have been studied in relation to the regulation of this catabolic program, but how they specifically regulate the initiation or progression of the disease is poorly understood. Here, we demonstrate that cartilage-specific ablation of Nuclear factor of activated T cells c1 (Nfatc1) in Nfatc2(-/-) mice leads to early onset, aggressive OA affecting multiple joints. This model recapitulates features of human OA, including loss of proteoglycans, collagen and aggrecan degradation, osteophyte formation, changes to subchondral bone architecture, and eventual progression to cartilage effacement and joint instability. Consistent with the notion that NFATC1 is an OA-suppressor gene, NFATC1 expression was significantly down-regulated in paired lesional vs. macroscopically normal cartilage samples from OA patients. The highly penetrant, early onset, and severe nature of this model make it an attractive platform for the preclinical development of treatments to alter the course of OA. Furthermore, these findings indicate that NFATs are key suppressors of OA, and regulating NFATs or their transcriptional targets in chondrocytes may lead to novel disease-modifying OA therapies.

Indexed as

AnimalsCartilage, ArticularChondrocytesGene Expression RegulationImmunohistochemistryMiceMice, KnockoutModels, BiologicalNFATC Transcription FactorsOsteoarthritisReal-Time Polymerase Chain ReactionX-Ray MicrotomographyNfatc1 protein, mouseNfatc2 protein, mouseNFATC Transcription Factors

Identifiers

PMID24248346
PMCPMC3856808
OpenAlexW1967342160

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.